期刊文献+

包裹多柔比星微球骨水泥体内外抗肿瘤活性研究 被引量:2

Antitumor effect of calcium phosphate cement incorporating doxorubicin microspheres
下载PDF
导出
摘要 目的观察包裹载多柔比星微球骨水泥的抗肿瘤活性。方法将细胞密度为1×106个/ml的SaoS-2细胞悬液,接种培养5d。用CCK-8试剂在免疫酶标仪上测定其吸光度值。用生理盐水调整细胞数为2×107/ml,取0.2ml肿瘤细胞于每只裸鼠左臀部消毒后皮下接种。从生理盐水调整的细胞数为2×107/ml的细胞悬液中取0.1ml,再分别加入3种已配制好的骨水泥浸提液0.1ml,分别按高、中、低剂量注射于每只裸鼠右耳后、左耳后及右臀部。每天观察裸鼠的活动、注射部位的皮肤和肿瘤生长情况。于实验第12天称瘤体质量并计算抑瘤率,常规HE染色观察。结果不同剂量组的包裹多柔比星微球骨水泥浸提液有一定抑制肿瘤生长的作用。各组浸提液对细胞增殖的抑制作用存在显著差异,以高剂量组最强,低剂量组最弱。各浸提液组均有明显的抑瘤作用。高剂量组抑瘤率达61.0%(P<0.05),剂量越小,抑瘤率也越小。HE染色后,大剂量浸提液组中可出现广泛的肿瘤坏死,肿瘤数量明显较少,而小剂量的浸提液抑瘤作用不明显,和模型组的肿瘤组织差异不明显。结论包裹多柔比星骨水泥的浸提液在体外和体内都具有良好的抗肿瘤活性。 Objective To investigate the antitumor effect of calcium phosphate cement incorporated with doxorubicin microspheres.Methods The absorbance at 490 nm of SaoS-2 cells cultured for 5 days in the media containing the extract of the cement incorporating doxorubicin microspheres was measured using Cell Counting Kit-8.SaoS-2 cells were adjusted to the density of 2×10^7 ml^-1 and injected into the left buttock of nude mouse in the volume of 0.2 ml.The cell suspension(0.1 ml) mixed with an equal volume of the cement extract were injected into the right buttock and on the back of the bilateral ears of nude mice.At 12 days after the cell injection,the tumor tissues were obtained and weighed to calculate the tumor inhibition rate,and the pathological samples were observed with HE staining.Results The extract of the bone cement containing doxorubicin microspheres showed inhibitory effects on the tumor growth in a dose-dependent manner.The tumor inhibition rate reached 61.0% in high-dose group.Tumor necrosis was found in high dose group,but virtually absent in low-dose group.Conclusion CPC containing doxorubicin PLGA microspheres can inhibit tumor cell growth both in vitro and in vivo.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第2期278-283,共6页 Journal of Southern Medical University
基金 广东省科技计划项目(2007B031003009)
关键词 磷酸钙骨水泥 微球 多柔比星 抗肿瘤活性 calcium phosphate cement microspheres doxorubicin tumor inhibition
  • 相关文献

参考文献27

  • 1Capranico G, Tinelli S, Zunino F. Resealing and persistence of DNA breaks produced by 4-demethoxydannorubicin in P388 leukemia cells[J]. Chem Biol interact, 1989, 72 (1-2): 113-23.
  • 2Zhang J, Clark JR, Herman EH, et al. Doxombiein-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187 [J]. J Mol Cell Cardiol, 1996, 28 (9): 1931-43.
  • 3Odom AL, Hatwig CA, Stanley JS, et al. Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine [J]. Biochem Pharmacol, 1992, 43(4): 831-6.
  • 4Takemura G, Fujiwara H. Morphological aspects of apoptosis in heart diseases[ J]. J Cell Mol Med, 2006, 10(1): 56-75.
  • 5Hu T, Le Q, Wu Z, et al. Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxombicin-loaded poly-beta-hydroxybutyrate microspheresEJ]. J Pharm Biomed Anal, 2007, 43(1): 263-9.
  • 6Amriteand AC, Kompeila UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration[J]. J Pharm Pharmacol, 2005, 57(12): 1555-63.
  • 7Amrite AC, Edelhauser HF, Singh SR, et al. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration[J ]. Mol Vis, 2008, 14:150-60.
  • 8Qi XP, Ye JD, Wang YJ, et al. Improved injectability and in vitro degradation of a calcium phosphate cement containing poly (lactide-co-glycolide) microspheres[J]. Acta Biomater, 2008, 4(6): 1837-45.
  • 9谭红香,叶建东.PLGA包埋硫酸庆大霉素缓释微球的制备及体外释放行为[J].中国抗生素杂志,2007,32(11):682-684. 被引量:15
  • 10Qi XP, Ye JD. Mechanical and rheological properties and injectability of calcium phosphate cement containing poly (lactic-co-glycolic acid) microspheres [C]. Materials Science and Engineering, 2009.

二级参考文献11

  • 1段尧,易宜昌,聂中越.硫酸庆大霉素缓释片的制备及其体外释放度的试验研究[J].中国现代应用药学,2006,23(S1):635-636. 被引量:3
  • 2Deacon J M, Pagliaro A J, Zelicof S B, et al. Current concept review Prophylactic use of antibiotics for procedures after total hip replacement [J]. J Bone Joint Surg Am, 1996,78(11) : 1755-1770.
  • 3Baro M, Sanchez E, Delgado A, et al. In vitro-in vivo characterization of gentamicin bone implants [J]. J Control Release,2002,83(3):353-364.
  • 4Virto M R, Elorza B, Torrado S, et al. Improvement of gentamicin poly (D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures[J]. Biomaterials,2007,28(5):877-885.
  • 5Li H Y, Chang J. Preparation Characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres [J]. J Control Release, 2005,107 (3) : 463-473.
  • 6Chang H-I, Perrie Y, Coombes A G A. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone [J]. J Control Release,2006, 110(2) :414-421.
  • 7Anderson J M, Shire M S. Biodegradation and biocompatibility of PLA and PLGA microspheres [J]. Advanced Drug Delivery Reviews, 1997,28 (1) : 5 - 24.
  • 8Singh M, Shirley B, Bajwa K, et al. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles [J]. J Control Release, 2001,70 ( 1 ) : 21 - 28.
  • 9Lu L, Stamatas G N, Mikos A G. Controlled release of transforming growth factor betal from biodegradable polymer microparticles [J]. J Biomed Mater Res,2000,50(3): 440-451.
  • 10Sivakumar M, Panduranga Rao K. Preparation characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres [J]. Biomaterials,2002,23(15) :3175-3181.

共引文献14

同被引文献29

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部